Dasatinib plus chemotherapy to achieve full donor chimerism and complete molecular remission in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia

Pediatr Blood Cancer. 2013 Oct;60(10):1727-8. doi: 10.1002/pbc.24618. Epub 2013 Jun 4.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Dasatinib
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Living Donors*
  • Male
  • Philadelphia Chromosome*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / prevention & control*
  • Protein Kinase Inhibitors / administration & dosage*
  • Pyrimidines / administration & dosage*
  • Recurrence
  • Remission Induction
  • Thiazoles / administration & dosage*
  • Time Factors
  • Transplantation Chimera*
  • Transplantation, Homologous

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Dasatinib